Scynexis (SCYX) FCF Margin Growth (3y) (2016 - 2025)
Scynexis (SCYX) FCF Margin Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 253.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1,444.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -990.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2,377.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1,484.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4,765.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1,067.00 |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 159,514.00 |
| Sep 30, 2025 | -116,638.00 |
| Jun 30, 2025 | 85,497.00 |
| Mar 31, 2025 | -62,067.00 |
| Dec 31, 2024 | 318,062.00 |
| Sep 30, 2024 | 337,579.00 |
| Mar 31, 2024 | -28,407.00 |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | 787,381.00 |
| Dec 31, 2021 | 540,849.00 |
| Sep 30, 2021 | 645,105.00 |
| Mar 31, 2021 | 1.29 Mn |
| Jun 30, 2019 | 43,791.00 |
| Mar 31, 2019 | 386,406.00 |
| Dec 31, 2018 | -19,062.00 |
| Sep 30, 2018 | -70,469.00 |
| Jun 30, 2018 | 51,562.00 |
| Mar 31, 2018 | -559,935.00 |
| Dec 31, 2017 | -789,086.00 |
| Sep 30, 2017 | -165,105.00 |